UW Medicine & Fred Hutch Research Center Awarded $12M to study MCC
April 17, 2019
On April 16th, Fred Hutch news shared the exciting announcement that “A multidisciplinary team from University of Washington and Fred Hutchinson Cancer Research Center has received a five-year, $12 million grant to study Merkel cell carcinoma, a deadly form of skin cancer. Dr. Paul Nghiem, a skin cancer researcher at UW and Fred Hutch, is the principal investigator of the grant.”
This funding, specifically recognized as a P01 grant from the National Institutes of Health, will allow this collaborative team to accelerate their research into three major areas, surrounding:
- Immune responses to cancer-causing viruses
- T-cell therapy for MCC
- Why do checkpoint inhibitors fail in MCC?